We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Simultaneous Measurement of Electroencephalography (EEG) and Functional Magnetic Resonance Imaging (fMRI) in Patients With Alcoholism

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00216905
First Posted: September 22, 2005
Last Update Posted: June 2, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Ludwig-Maximilians - University of Munich
  Purpose
Investigation of inpatients with alcoholism after detoxification with simultaneous Electroencephalography (EEG) and functional Magnetic Resonance Imaging (fMRI).

Condition
Alcoholism

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Neurobiological Correlates of Disturbed Cognitive Function in Patients With Alcoholism - Simultaneous Measurement With EEG and fMRI

Resource links provided by NLM:


Further study details as provided by Ludwig-Maximilians - University of Munich:

Enrollment: 25
Study Start Date: October 2004
Study Completion Date: December 2009
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with alcohol use disorder
Criteria

Inclusion Criteria:

  • Age of 18 or more
  • Inpatient with alcoholism after detoxification.

Exclusion Criteria:

  • Neurological disease
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00216905


Locations
Germany
Department of Psychiatry, Ludwig-Maximilians-University
Munich, Bavaria, Germany, 80336
Sponsors and Collaborators
Ludwig-Maximilians - University of Munich
Investigators
Principal Investigator: Christoph Mulert, M.D. Department of Psychiatry, Ludwig-Maximilians-University
  More Information

Responsible Party: C. Mulert, MD, University of Munich
ClinicalTrials.gov Identifier: NCT00216905     History of Changes
Other Study ID Numbers: Mulert_LMU_EEG/fMRI
EK166/02
First Submitted: September 19, 2005
First Posted: September 22, 2005
Last Update Posted: June 2, 2010
Last Verified: May 2010

Keywords provided by Ludwig-Maximilians - University of Munich:
Patients with alcoholism according to ICD-10 after detoxification

Additional relevant MeSH terms:
Alcoholism
Alcohol-Related Disorders
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders